Faculty

Margaret Madeleine

Research Associate Professor, Epidemiology

206-667-4629
mmadelei@uw.edu

Education

PhD Epidemiology, University of Washington, 1996
MPH Epidemiology, Yale University, 1991

Contact

206-667-4629
mmadelei@uw.edu

Fred Hutchinson Cancer Research Center
Box 358080
Epidemiology Program
1100 Fairview Ave N.
Mailstop: M4-C313
Seattle, WA 98109

Bio

Margaret M. Madeleine, MPH, PhD, is a Research Associate Professor in the Department of Epidemiology in the School of Public Health at the University of Washington and an Associate Member of the Program in Epidemiology at the Fred Hutchinson Cancer Research Center. She received her MPH in Epidemiology from Yale in 1991 and PhD from the UW in 1996. She has been a key member of the Seattle HPV research group, and focuses on the epidemiology of HPV related cancers. Prior grants have focused on the role of inflammation and immune genetics in cancer. Current projects focus on the role of HPV vaccination in prevention of HSIL and uptake of HPV vaccination in Washington State.

Research Interests

Dr. Madeleine's major research focus is on the molecular epidemiology of pathogens and our immune response to them that may be associated with cancer development and prognosis. She is interested in the common drivers behind the role that chronic subclinical inflammation (such as occurs with age, viral infection, and UV exposure) plays in cancer. Her current work includes post-licensure trials of the HPV vaccine.

Recent Publications (PubMed)

Time and geographic variations in human papillomavirus vaccine uptake in Washington state.
(2021 Jul 31)
Prev Med 153(): 106753
Pourebrahim N, Shah P, VoPham T, Doody DR, Bell TR, deHart MP, Madeleine MM

Barriers to Human Papillomavirus Vaccine Series Completion among Insured Individuals in an Integrated Healthcare Setting.
(2021)
Infect Dis (Auckl) 14(): 11786337211018712
Kamineni A, Blasi PR, Gundersen GD, Oliver M, Dunn JB, Galloway DA, Madeleine MM

Disparities in post-operative surveillance testing for metastatic recurrence among colorectal cancer survivors.
(2021 May 24)
J Cancer Surviv
Sanchez JI, Shankaran V, Unger JM, Madeleine MM, Espinoza N, Thompson B

Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.
(2021 Apr)
Cancer Invest 39(4): 315-320
Wagner MJ, Pollack SM, Cranmer LD, Thompson MJ, Maxwell S, Wright S, Khaki AR, Madeleine MM, Grivas P, Kuderer NM, Lyman GH, Loggers ET

Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
(2021 Apr 17)
Carcinogenesis 42(3): 369-377
Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, Palles C, Ye W, Gammon MD, Iyer PG, Anderson LA, Liu G, Wu AH, Dai JY, Chow WH, Risch HA, Lagergren J, Shaheen NJ, Bernstein L, Corley DA, Prenen H, deCaestecker J, MacDonald D, Moayyedi P, Barr H, Love SB, Chegwidden L, Attwood S, Watson P, Harrison R, Ott K, Moebus S, Venerito M, Lang H, Mayershofer R, Knapp M, Veits L, Gerges C, Weismüller J, Gockel I, Vashist Y, Nöthen MM, Izbicki JR, Manner H, Neuhaus H, Rösch T, Böhmer AC, Hölscher AH, Anders M, Pech O, Schumacher B, Schmidt C, Schmidt T, Noder T, Lorenz D, Vieth M, May A, Hess T, Kreuser N, Becker J, Ell C, Ambrosone CB, Moysich KB, MacGregor S, Tomlinson I, Whiteman DC, Jankowski J, Schumacher J, Vaughan TL, Madeleine MM, Hardie LJ, Buas MF

Show complete publication list